TSLCX | VSCAX | TSLCX / VSCAX | |
Total Expense Ratio | 2.05 | 1.12 | 183% |
Annual Report Gross Expense Ratio | 2.14 | 1.12 | 191% |
Fund Existence | 13 years | 26 years | - |
Gain YTD | -7.333 | -3.573 | 205% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 1000 | 1000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 78.1M | 6.48B | 1% |
Annual Yield % from dividends | 0.00 | 0.37 | - |
Returns for 1 year | -19.81 | 0.16 | -12,674% |
Returns for 3 years | -29.65 | 29.03 | -102% |
Returns for 5 years | -41.76 | 116.10 | -36% |
Returns for 10 years | -64.46 | 10.55 | -611% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RAGHX | 26.47 | -0.19 | -0.71% |
Virtus KAR Health Sciences A | |||
RWIHX | 68.56 | -0.74 | -1.07% |
American Funds Capital World Gr&Inc R5E | |||
RNTTX | 47.90 | -0.68 | -1.40% |
Russell Inv International Devd Mkts M | |||
MOSAX | 9.41 | -0.15 | -1.57% |
MassMutual Overseas A | |||
JSERX | 51.70 | -0.99 | -1.88% |
JPMorgan Small Cap Equity R5 |